glp 1 issues GLP-1 for Weight Loss and Diabetes GLP-1 Agonists In Obesity

Read more on MIMS To view or add a comment, sign in Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns Patients taking weight-loss drugs often make 5 critical mistakes, doctor warnsGrowing research suggests that GLP-1s potentially have benefits beyond weight loss, with stronger evidence for cardiovascular and kidney health

GLP-1RAs and Renal Outcomes Accumulating clinical evidence demonstrates that GLP-1 RAs have beneficial effects on renal outcomes

This is clinically important because a physiological pulse pattern does not produce the receptor desensitization or side effect profile associated with direct GH injection

Implications for practice Following more than 6 months where initiation of GLP-1 RAs was not permitted in the UK, clinicians will have been pleased to read the National Drug Safety Alert published earlier this month, which confirms that there are now sufficient supplies of daily oral semaglutide (Rybelsus) available in the UK to allow new initiations as well as supplying those already on treatment